← Eichor
Study identifier: NCT06135571 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

Condition: Colorectal Cancer · Lymph Node Metastasis  ·  Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

PhaseN/A
Planned participants3000
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the the pattern of metastasis of the No.253 lymph node in colorectal cancer. The main questions it aims to answer are: 1. What are the risk factors for metastasis to the No.253 lymph node? 2.What is the prognosis for patients with metastasis to the No.253 lymph node? Patients with descending colon cancer, sigmoid colon cancer, and rectal cancer who undergo curative surgery with dissection of the No.253 lymph node are included in this study

This description comes directly from the study's public registry record.

Talk to the study team

Qian Liu, Dr.  ·  13601008906  ·  fcwpumch@163.com

Mingguang Zhang, Dr.  ·  +8613261967603  ·  zmgslimshady@163.com

Always discuss trial participation with your own doctor first.

Locations (4)

Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting
China-Japan Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting
Beijing Cancer HospitalBeijing, Beijing Municipality, ChinaRecruiting
Chinese PLA General HospitalBeijing, Beijng, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06135571